Helmut Albrecht to Anti-Retroviral Agents
This is a "connection" page, showing publications Helmut Albrecht has written about Anti-Retroviral Agents.
Connection Strength
0.845
-
HIV community viral load trends in South Carolina. Int J STD AIDS. 2017 03; 28(3):265-276.
Score: 0.522
-
Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet HIV. 2019 06; 6(6):e364-e372.
Score: 0.159
-
Rare case of rilpivirine-induced severe allergic hepatitis. J Antimicrob Chemother. 2013 Feb; 68(2):484-6.
Score: 0.101
-
Cost-Effectiveness Analysis of Early vs Late Diagnosis of HIV-Infected Patients in South Carolina. South Med J. 2018 06; 111(6):355-358.
Score: 0.037
-
Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994-2011. Metab Syndr Relat Disord. 2013 Dec; 11(6):417-26.
Score: 0.027